GJD2: A Protein Involved in Neuronal Excitability and Cellular Communication

Target Name: GJD2

NCBI ID: G57369

GJD2: A Protein Involved in Neuronal Excitability and Cellular Communication

GJD2 (Connexin-36) is a protein that is expressed in the brain and is known for its role in the development and maintenance of neuronal excitability. The protein is composed of two subunits, Connexin-36A and Connexin-36B, which are held together by a disulfide bond.

GJD2 is a critical protein for the proper functioning of the nervous system, as it helps to regulate the flow of calcium ions into neurons. When calcium ions are released from the inside of a neuron, they can cause a rapid and potentially harmful increase in muscle tension, which can lead to movement disorders such as spasticity. By its role in regulating the flow of calcium ions, GJD2 helps to prevent these types of disorders from occurring.

In addition to its role in regulating calcium ions, GJD2 is also involved in the formation of new neurons. When a neuron is born, GJD2 helps to guide the process of its development and formation. This is important for the formation of new neurons that can replace damaged or dying cells, which is critical for maintaining the integrity of the nervous system.

GJD2 is also involved in the regulation of pain. When a person experiences pain, GJD2 helps to transmit this information to the brain, where it is processed and understood. This is important for the development of pain relief strategies, as understanding the source of pain is key to effective treatment.

GJD2 is also a potential drug target for various neurological disorders, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. These disorders are characterized by the progressive loss of brain cells and the development of neurodegeneration. GJD2 may be a valuable biomarker for these disorders, as its levels are often reduced in the brains of people with these conditions.

GJD2 is also a potential biomarker for certain types of cancer, including neuroblastoma. These are aggressive forms of cancer that can arise from the cells that normally produce neurotransmitters, such as GJD2. The loss of GJD2 has been observed in the brains of people with neuroblastoma, and these levels may be used as a biomarker for the disease.

In conclusion, GJD2 is a protein that is expressed in the brain and plays a critical role in the development and maintenance of neuronal excitability. It is involved in the regulation of calcium ions, the formation of new neurons, and the regulation of pain. GJD2 may also be a valuable biomarker for various neurological disorders, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Further research is needed to fully understand the role of GJD2 in the nervous system and its potential as a drug target.

Protein Name: Gap Junction Protein Delta 2

Functions: One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell

More Common Targets